Dr. John Krystal

Biography

John Krystal is the Robert L. McNeil, Jr. Professor of Translational Research in the Department of Psychiatry and the Department of Neuroscience at Yale University. He is a leading expert in the fields of alcoholism, post-traumatic stress disorder, schizophrenia, and depression. His work incorporates elements of psychopharmacology, neuroimaging, molecular genetics, and computational neuroscience, focusing on the neurobiology of treatment for these disorders. Dr. Krystal is best known for his pioneering discovery of the rapid antidepressant effects of ketamine in patients suffering from depression. He is a member of the U.S. National Academy of Medicine and has served various advisory and review capacities, including positions with the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Mental Health (NIMH), the Wellcome Trust, the Brain and Behavior Research Foundation, the Broad Institute, and the Karolinska Institutet. His past leadership roles include chair of the NIMH Board of Scientific Counselors (2005-2007), president of the American College of Neuropsychopharmacology (2012), and president of the International College of Neuropsychopharmacology (2016-2018). Currently, he is the co-chair of the Neuroscience Forum (NeuroForum) at the National Academies of Sciences, Engineering, and Medicine, and serves as an editor for the journal Biological Psychiatry, which has an impact factor of 11.982.

Research Interests